Journal of the American Society of Nephrology : JASN · 1993
Oxidative modification of low-density lipoproteins by mesangial cells.
Сравнительное исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Keane W F, O'Donnell M P, Kasiske B L, Kim Y
Аннотация
Because hypercholesterolemia and mesangial cell proliferation may be important in the pathogenesis of glomerulosclerosis, the effects of low-density lipoprotein (LDL) on human mesangial cell proliferation were evaluated. Native LDL (20 to 200 micrograms/mL) caused a dose-dependent increase in (3H)thymidine incorporation and increased mesangial cell numbers over 96 h. The mitogenic effect of LDL was partially blocked by the inhibition of cytochrome P-450, but not by the inhibition of cyclooxygenase or lipoxygenase pathways. Higher LDL concentrations (1,000 to 2,000 micrograms/mL) inhibited (3H)thymidine incorporation and reduced cell numbers, possibly as a result of the oxidative modification of LDL, indicated by an increase in thiobarbituric reactive substances. This peroxidation of LDL involved superoxide, because superoxide dismutase and butylated hydroxytoluene prevented it, whereas hydroxyl radical scavengers were without effect. Native LDL subjected to chemical oxidation by copper sulfate also inhibited mesangial cell proliferation. These results suggest that low concentrations of LDL may stimulate human mesangial cell proliferation, which may, in turn, cause the production of reactive oxygen molecules. Moreover, the oxidative modification of LDL may mediate the toxic effects of high LDL concentrations on human mesangial cells.
Предметные рубрики MeSH
AntioxidantsArachidonic AcidButylated HydroxytolueneCatalaseCell DivisionCells, CulturedCyclooxygenase InhibitorsCytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme SystemDNA ReplicationDeferoxamineGlomerular MesangiumGlomerulosclerosis, Focal SegmentalHumansHydroxyureaIndomethacinKetoconazoleLipoproteins, LDLLipoxygenase InhibitorsMasoprocolOxidation-ReductionSuperoxide DismutaseThiobarbituric Acid Reactive Substances